HCW Biologics Inc. (HCWB)
HCWB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.26
-14.87% on the day
Market cap
$2.8M
Nano cap
Revenue · 2025
$54K
No prior year to compare
Net income · 2025
-$8.0M
-14677.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1828673/000119312526134934/0001193125-26-134934-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | HCWB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001828673 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $54K |
| Net income | -$8.0M |
| Operating income | -$13.2M |
| Net margin | -14677.1% |
| Operating margin | -24270.7% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $2.0M |
| Total assets | $24.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 52.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2026-10-02 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-09-24 |
| Latest proxy | DEF 14A | 2026-10-01 |
Source: SEC EDGAR submissions feed, 336 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| KAPA | Kairos Pharma Ltd. | $0.8287 | -0.40% | $2.8M |
| MBIO | Mustang Bio Inc. | $0.3768 | -8.63% | $2.9M |
| PRFX | PRF Technologies Ltd. | $0.8180 | -4.88% | $2.9M |
| ONCO | Onconetix Inc. | $0.5550 | -6.00% | $2.9M |
| DCOY | Decoy Therapeutics Inc. | $1.24 | -13.29% | $3.0M |
| GOVX | GeoVax Labs Inc. | $0.2656 | -5.92% | $2.7M |
| XRTX | XORTX Therapeutics Inc. Common Shares | $1.68 | -2.33% | $3.1M |
| APVO | Aptevo Therapeutics Inc. | $1.73 | -5.79% | $3.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier